Unknown PHASE3 INTERVENTIONAL 2-arm NCT03633552

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

A Single-blind, Randomized, Clinical Trial Comparing the Efficacy of 6 Cycles Versus 12 Cycles Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

Sponsor: Mashhad University of Medical Sciences

Conditions Anaplastic Astrocytoma of Brain Glioblastoma Multiforme of Brain

Interventions Temozolomide

Updated 6 times since 2018 Last updated: Aug 13, 2018 Started: Mar 3, 2018 Primary completion: Mar 3, 2021 Completion: Apr 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Anaplastic Astrocytoma of Brain and Glioblastoma Multiforme of Brain and is currently ongoing. Mashhad University of Medical Sciences leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Sep 2018 — Jan 2021 [monthly]

Recruiting PHASE3

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mashhad, Iran